**Summary:**
This notice, reference DCGI Misc. 2016 33, from the Directorate General of Health Services, Central Drugs Standard Control Organisation (CDSCO), Ministry of Health & Family Welfare, Government of India, announces an interactive meeting with stakeholders to discuss transparency and ease of regulatory services at CDSCO. The meeting is scheduled for March 30, 2016, at 2:30 PM in the Conference Room, 1st Floor, CDSCO HQ, FDA Bhawan, Kotla Road, New Delhi. Industry associations of drugs, cosmetics, and medical devices are invited to participate. Each association is requested to nominate no more than two participants, with nominations to be submitted via email to dcinic.in by March 28, 2016. Dr. G. N. Singh, Drugs Controller General of India, issued the notice.
Key Entities Referenced
Central Drugs Standard Control Organisation: A national regulatory body in India responsible for the regulation of pharmaceuticals and medical devices.
FDA Bhawan, New Delhi: The location of the Central Drugs Standard Control Organisation (CDSCO) headquarters in New Delhi, Delhi.
Ministry of Health Family Welfare: A ministry of the Government of India responsible for public health.
Dr. G. N. Singh: The Drugs Controller General of India at the time of the notice.
Drugs Controller General India: The title/position of Dr. G.N. Singh, head of CDSCO.
CDSCOHQ: Abbreviation for Central Drugs Standard Control Organisation Headquarters
Kotla Road, New Delhi: Address of FDA Bhawan, New Delhi, Delhi.
All Industry Associations of Drugs, Cosmetics and Medical Devices: The recipients of the meeting notice, representing various industry associations related to pharmaceuticals, cosmetics, and medical devices.
DCG(I) / Misc. / 2016 — (33)
Government of India
Ministry of Health & Family Welfare
Directorate General of Health Services
Central Drugs Standard Control Organisation
FDA Bhawan, New Delhi
Meeting Notice Dated: “i } - 05 ~ -%ZBolb
As per our earlier drill to have meeting with the stakeholders to understand their
issues and grievances for prompt disposal, it is decided to invite the members to have
interactive meeting on 30.03.2016 at 2:30 PM in Conference Room, 1° Floor, CDSCO(HQ),
FDA Bhawan, Kotla Road, New Delhi for steps / measures taken in recent months to bring
transparency and ease of regulatory services at CDSCO.
The nomination of participants may be sent to this office in advance through email at
dci@nic.in by 28.03.2016.
Each association is requested to depute not more than two participants for the
meeting.
(Dr. G. N. Singh)
Drugs Controller General (India)
To
All Industry Associations of Drugs, Cosmetics and Medical Devices
Copy to
1. PS to JS (KLS)
2. JDC(ER) / JDC(VGS)
3. DDC (AKP) CDSCO (NZ)
4. Guard File